April 15 - 16, 2025 | US Eastern Time: 9 AM to 2 PM | Central Europe Time: 3 PM to 8 PM


$1200 

Seminar Registration Options: *

Learn More


This expanded training provides an in-depth analysis of FDA inspection processes, common observations, and prevention strategies. Participants will gain a deeper understanding of how to navigate FDA inspections successfully and proactively prevent regulatory findings such as Form 483 observations and warning letters.


By leveraging real-world case studies, interactive workshops, and mock scenarios, attendees will learn to identify root causes, develop CAPA plans, and establish best practices for long-term compliance.


This training ensures that professionals not only understand why FDA issues citations but also acquire the tools to prevent them from occurring.


WHY YOU SHOULD ATTEND:


This training is essential for professionals who:

  • Need to understand the FDA inspection process and avoid common compliance pitfalls.
  • Want to build strong SOPs and training programs to prevent observations.
  • Are responsible for CAPA development and deviation investigations.
  • Need to ensure data integrity, proper record-keeping, and robust documentation.
  • Seek to establish proactive compliance strategies to avoid regulatory enforcement.



WHO SHOULD ATTEND:

  • Quality Assurance Departments
  • Quality Control Departments
  • Regulatory Affairs Departments
  • Manufacturing Departments
  • Engineering Departments
  • Research and Development Departments
  • Compliance Departments
  • Production Departments
  • Documentation Departments
  • Operations Departments
  • Training and Development Departments

SEMINAR OBJECTIVES:

  • Master the FDA Inspection Process: Gain insights into pre-inspection preparation, inspection conduct, and post-inspection actions.
  • Understand the Top FDA Observations: Deep dive into common citations, including documentation failures, training deficiencies, and CAPA weaknesses.
  • Learn How to Conduct Effective Root Cause Analysis: Develop investigation strategies using case studies and mock FDA inspection exercises.
  • Ensure CAPA Effectiveness: Learn best practices for writing, implementing, and following up on CAPA plans.
  • Improve SOPs and Training Programs: Identify weaknesses in training approaches and standard procedures to enhance regulatory compliance.
  • Master Data Integrity and Documentation Compliance: Learn how to mitigate risks related to data integrity, missing records, and inadequate testing.
  • Implement Proactive Compliance Strategies: Shift from reactive fixes to proactive solutions for continuous improvement and inspection readiness.

AGENDA

DAY 1 (9 AM to 2 PM)

FDA Inspection Process & Common Observations

  • Understanding FDA Inspections & Regulatory Expectations
  • Decoding the FDA 483 Process & Establishment Inspection Reports
  • Observation Type 1: Inadequate Documentation & Record-Keeping (Workshop: Reviewing FDA citations and improving documentation)
  • Observation Type 2: Employee Training Deficiencies (Exercise: Developing a compliant training program)
  • Observation Type 3: Failure to Follow SOPs (Case study analysis of real FDA citations)

DAY 2 (9 AM to 2 PM)

Prevention Strategies & CAPA Development

  • Observation Type 4: CAPA Deficiencies & Root Cause Investigations (Hands-on CAPA writing exercise)
  • Observation Type 5: Facility & Equipment Failures (Mock facility walkthrough identifying potential 483 risks)
  • Observation Type 6: Data Integrity & Reporting Issues (Real-world case study on falsified records & FDA enforcement)
  • Developing a Culture of Compliance & Continuous Improvement (Interactive strategy session)



Course Director: MEREDITH CRABTREE 

Meredith Crabtree has over 30 years’ experience in regulated industries, ranging from Blood, Plasma, Tissue, Laboratory, Pharma, Medical Device, Cosmetics, Supplements, and Animal Health. This includes manufacturing, packaging, labelling and distribution operations. Meredith is the owner of MLKC Consulting is s a Quality Consultant specializing in product label reviews, 3rd party inspections, Consent Decree and Recall support. She also performs regulatory assessments and Quality trainings.